OpenBilldrug price receipt

NADAC week of 2026-10-14

INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL

For 10 mL

Pharmacies pay

$69.55 filed

10 × $6.95452 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$84.98 estimated

$69.55 + $10.43 (15%) + $5.00 fee per fill = $84.98

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-05-20 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as insulin aspart, under the trade name “Insulin Aspart Protamine and Insulin Aspart Mix 70/30”.

FDA gives its dosage form as injection, suspension and its route as subcutaneous.

The labeler, the company named on the label, is Novo Nordisk Pharma, Inc.

FDA’s Established Pharmacologic Class for it is Insulin Analog.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 73070-0200-11.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $69.55 for 10 mL (10 × $6.95452 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-05-20. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-05-20. The file is new; the price is not.

The NDC

Other strengths, forms and brands

10 other products in the NADAC file share the FDA nonproprietary name insulin aspart with INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL.

ProductPharmacies pay per unitMedicare per unit
FIASP PUMPCART 100 UNIT/ML
brand · injection, solution
$8.56863 per ML filed
eff. 2026-09-23
$2.362 per ML derived
Part B limit 2026 Q4
INSULIN ASPART 100 UNIT/ML VL
generic · injection, solution
$6.95482 per ML filed
eff. 2026-05-20
$7.14145 per ML filed
Part D 2024 average
INSULIN ASPART FLEXPEN 100 UNIT/ML PEN
generic · injection, solution
$8.96069 per ML filed
eff. 2026-05-20
We don’t know yet
INSULIN ASPART PENFILL 100 UNIT/ML CARTRIDGE
generic · injection, solution
$8.57063 per ML filed
eff. 2026-05-20
We don’t know yet
INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 FLEXPEN
generic · injection, suspension
$8.9345 per ML filed
eff. 2026-05-20
We don’t know yet
INSULIN ASPART PROTAMINE-INSULIN ASPART MIX 70-30 VIAL this page
generic · injection, suspension
$6.95452 per ML filed
eff. 2026-05-20
We don’t know yet
NOVOLOG 100 UNIT/ML FLEXPEN
brand · injection, solution
$8.93506 per ML filed
eff. 2026-09-23
$8.89691 per ML filed
Part D 2024 average
NOVOLOG 100 UNIT/ML VIAL
brand · injection, solution
$6.93519 per ML filed
eff. 2026-09-23
$6.98008 per ML filed
Part D 2024 average
NOVOLOG MIX 70-30 FLEXPEN
brand · injection, suspension
$8.93705 per ML filed
eff. 2026-09-23
We don’t know yet
NOVOLOG MIX 70-30 VIAL
brand · injection, suspension
$6.92869 per ML filed
eff. 2026-09-23
We don’t know yet
NOVOLOG PENFILL 100 UNIT/ML
brand · injection, solution
$8.56929 per ML filed
eff. 2026-09-23
$6.232 per ML derived
Part B limit 2026 Q4

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

Its NADAC price is $6.95452 per ML filed.

Of the 56 other products in FDA’s Insulin Analog class priced per ML, 45 have a higher middle NADAC price and 11 a lower one. The one in the middle is ADMELOG 100 UNIT/ML VIAL, at $9.39379 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 10 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 10 mL in one package for this product’s NDC (“1 VIAL, GLASS in 1 CARTON (73070-200-11) / 10 mL in 1 VIAL, GLASS”), so the card starts at one package: 10 ML. Change it to match your prescription.